Evaluation of Gynecological Acceptability of 3 Health Care Products
NCT ID: NCT04327947
Last Updated: 2020-04-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
65 participants
INTERVENTIONAL
2019-11-06
2020-02-21
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Gynecological Acceptability of a Health Care Product
NCT04247022
Hyaluronic Acid and Vaginal Distress
NCT00890487
Performance and Safety of Hyalo Gyn Gel on the Treatment of Vaginal Atrophy in Postmenopausal Women
NCT04355403
Performance and Safety of Class IIb MD Celegyn® in VVA
NCT03823560
Oral Low-molecular Weight Hyaluronic Acid in the Treatment of Atrophic Vaginitis
NCT02014428
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
women, 18-39 y
Health volunteers, 18-39 y, with vaginal dryness
Hyaluronic acid - Research product 1
Health care product (intimate gel)
Hyaluronic acid - Research product 2
Health care product (intimate gel)
Hyaluronic acid - Comparator product
Health care product (intimate gel)
premenopause women
Health volunteers, 40 years to premenopause, with vaginal dryness
Hyaluronic acid - Research product 1
Health care product (intimate gel)
Hyaluronic acid - Research product 2
Health care product (intimate gel)
Hyaluronic acid - Comparator product
Health care product (intimate gel)
climacteric women
Health volunteers, climacteric, with vaginal dryness
Hyaluronic acid - Research product 1
Health care product (intimate gel)
Hyaluronic acid - Research product 2
Health care product (intimate gel)
Hyaluronic acid - Comparator product
Health care product (intimate gel)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Hyaluronic acid - Research product 1
Health care product (intimate gel)
Hyaluronic acid - Research product 2
Health care product (intimate gel)
Hyaluronic acid - Comparator product
Health care product (intimate gel)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Non-injured mucosa in the test region;
* Agreement to adhere to study procedures and requirements and attend the institute on the day(s) and time(s) determined for the evaluations;
* Ability to consent to their participation in the study;
* Age from 18 to 70 years old;
* Female participants;
* Vaginal dryness (slight minimum) - according to questions from the gynecologist.
Exclusion Criteria
* Skin pathology in the area of application of the product;
* Diabetes Mellitus type 1; insulin-dependent diabetes; presence of complications due to diabetes (retinopathy, nephropathy, neuropathy); presence of diabetes-related dermatoses (plantar ulcer, lipoid necrobiosis, annular granuloma, opportunistic infections); history of episodes of hypoglycemia, diabetic ketoacidosis and/or hyperosmolar coma;
* Current use of the following medications for topical or systemic use:
corticosteroids, immunosuppressants and antihistamines;
* Skin diseases: vitiligo, psoriasis, lupus, atopic dermatitis;
* History of reaction to the category of the tested product;
* Other diseases or medications that may directly interfere with the study or endanger the health of the research participant.
18 Years
70 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Herbarium Laboratorio Botanico Ltda
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Allergisa Pesquisa Dermato-Cosmética Ltda
Campinas, , Brazil
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
All-S-EP-076888
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.